US EditionSagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.
Summary by abc12/WJRT
13 Articles
13 Articles
All
Left
Center
7
Right
abc12/WJRT+12 Reposted by 12 other sources
Sagent and Qilu Announce Strategic Collaboration to Expand Access to Critical Injectables in U.S.
SCHAUMBURG, Ill., July 7, 2025 /PRNewswire/ -- Sagent Pharmaceuticals ("Sagent"), a leading provider of pharmaceuticals to the US market, and Qilu Pharmaceutical Co., Ltd. ("Qilu"), a leading vertically integrated pharmaceutical company based in China, today announced a strategic collaboration to…
·Flint, United States
Read Full ArticleCoverage Details
Total News Sources13
Leaning Left0Leaning Right0Center7Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
